Foreign-Trade Zone (FTZ) 35-Philadelphia, Pennsylvania, Notification of Proposed Production Activity, Piramal Pharma Solutions (Pharmaceutical Products), Sellersville, Pennsylvania, 52505-52506 [2022-18470]

Download as PDF Federal Register / Vol. 87, No. 165 / Friday, August 26, 2022 / Notices at the end of the meeting. Members of the public may also submit written comments; the comments must be received in the Regional Programs Unit within 30 days following the meeting. Written comments may be emailed to Barbara de La Viez at ero@usccr.gov. Persons who desire additional information may contact the Regional Programs Unit at (202) 539–8246. Records and documents discussed during the meeting will be available for public viewing as they become available at www.facadatabase.gov. Persons interested in the work of this advisory committee are advised to go to the Commission’s website, www.usccr.gov, or to contact the Regional Programs Unit at the above phone number or email address. Agenda Thursday, September 8, 2022; 9:30 a.m. (ET) I. Welcome and Roll Call II. Briefing on Algorithms in Connecticut III. Question and Answer Between Panelists and Committee Members IV. Public Comment V. Adjournment Dated: August 22, 2022. David Mussatt, Supervisory Chief, Regional Programs Unit. [FR Doc. 2022–18362 Filed 8–25–22; 8:45 am] BILLING CODE P DEPARTMENT OF COMMERCE Economic Development Administration lotter on DSK11XQN23PROD with NOTICES1 Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Petition by a Firm for Certification of Eligibility To Apply for Trade Adjustment Assistance, and Adjustment Proposals The Department of Commerce will submit the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995, on or after the date of publication of this notice. We invite the general public and other Federal agencies to comment on proposed, and continuing information collections, which helps us assess the impact of our information collection requirements and minimize the public’s reporting burden. Public comments were previously requested via the Federal Register on June 24, 2022, during a 60-day comment period. This notice allows for an additional 30 days for public comments. VerDate Sep<11>2014 16:59 Aug 25, 2022 Jkt 256001 Agency: Economic Development Administration (EDA), U.S. Department of Commerce. Title: Petition by a Firm for Certification of Eligibility to Apply for Trade Adjustment Assistance, and Adjustment Proposals. OMB Control Number: 0610–0091. Form Number(s): ED–840P. Type of Request: Extension without change of a currently approved information collection. Number of Respondents: 300 (150 petitions for certification and 150 adjustment proposals). Average Hours per Response: 53 hours for petitions for certification and 120 hours for adjustment proposals. Burden Hours: 25,950 (7,950 hours for petitions for certification and 18,000 for adjustment proposals). Needs and Uses: The information collected on Form ED–840P, Petition by a Firm for Certification of Eligibility to Apply for Trade Adjustment Assistance, and relevant supporting documentation is used to determine whether a firm satisfies the eligibility and programmatic requirements contained in chapters 3 and 5 of title II of the Trade Act of 1974, as amended (19 U.S.C. 2341). If certified as eligible for Trade Adjustment Assistance following submission of Form ED–840P, firms must create an EDA-approved Adjustment Proposal in order to receive Trade Adjustment Assistance. The statutory authorization for the TAAF program sunset in two stages. First, on July 1, 2021, the TAAF program reverted to more limited eligibility criteria. Second, as of June 30, 2022, assistance could not be provided to new firms. After that date, assistance could only be provided to firms that had previously submitted a petition under the TAAF program. EDA wishes to extend the current information collection for the TAAF program so that EDA may continue to review and approve adjustment proposals from certified firms, and in case the TAAF program is re-authorized by Congress. Affected Public: Businesses or other for-profit organizations. Frequency: During application for Trade Adjustment Assistance. Respondent’s Obligation: Mandatory. Legal Authority: Chapters 3 and 5 of title II of the Trade Act of 1974, as amended (19 U.S.C. 2341). This information collection request may be viewed at www.reginfo.gov. Follow the instructions to view the Department of Commerce collections currently under review by OMB. Written comments and recommendations for the proposed information collection should be PO 00000 Frm 00006 Fmt 4703 Sfmt 4703 52505 submitted within 30 days of the publication of this notice on the following website www.reginfo.gov/ public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function and entering either the title of the collection or the OMB Control Number 0610–0091. Sheleen Dumas, Department PRA Clearance Officer, Office of the Chief Information Officer, Commerce Department. [FR Doc. 2022–18468 Filed 8–25–22; 8:45 am] BILLING CODE 3510–34–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–37–2022] Foreign-Trade Zone (FTZ) 35— Philadelphia, Pennsylvania, Notification of Proposed Production Activity, Piramal Pharma Solutions (Pharmaceutical Products), Sellersville, Pennsylvania Piramal Pharma Solutions submitted a notification of proposed production activity to the FTZ Board (the Board) for its facility in Sellersville, Pennsylvania under FTZ 35. The notification conforming to the requirements of the Board’s regulations (15 CFR 400.22) was received on August 19, 2022. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/ component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board’s website—accessible via www.trade.gov/ ftz. The proposed finished products are bempedoic acid and ezetimibe tablets (180/10 milligrams) (duty-free). The proposed foreign-status materials are bempedoic acid and ezetimibe (duty rate ranges from 4% to 6.5%). The request indicates that the materials are subject to duties under Section 301 of the Trade Act of 1974 (section 301), depending on the country of origin. The applicable Section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive E:\FR\FM\26AUN1.SGM 26AUN1 52506 Federal Register / Vol. 87, No. 165 / Friday, August 26, 2022 / Notices Secretary and sent to: ftz@trade.gov. The closing period for their receipt is October 5, 2022. A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov. Dated: August 23, 2022. Andrew McGilvray, Executive Secretary. [FR Doc. 2022–18470 Filed 8–25–22; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Bureau of Industry and Security Regulations and Procedures Technical Advisory Committee; Notice of Partially Closed Meeting The Regulations and Procedures Technical Advisory Committee will meet September 13, 2022, at 10:00 a.m., Eastern Daylight Time, via teleconference. The Committee advises the Office of the Assistant Secretary for Export Administration on implementation of the Export Administration Regulations (EAR) and provides for continuing review to update the EAR as needed. Agenda Public Session 1. Opening remarks by the Chairman 2. Opening remarks by the Bureau of Industry and Security 3. Presentation of papers or comments by the Public 4. Regulations Update 5. Working Group Reports 6. Automated Export System Update lotter on DSK11XQN23PROD with NOTICES1 Closed Session 7. Discussion of matters determined to be exempt from the provisions relating to public meetings found in 5 U.S.C. App. §§ 10(a)(1) and 10(a)(3). The open session will be accessible via teleconference to participants on a first come, first serve basis. To join the conference, submit inquiries to Ms. Yvette Springer at Yvette.Springer@ bis.doc.gov, no later than September 6, 2022. To the extent that time permits, members of the public may present oral statements to the Committee. The public may submit written statements at any time before or after the meeting. However, to facilitate the distribution of public presentation materials to the Committee members, the Committee VerDate Sep<11>2014 16:59 Aug 25, 2022 Jkt 256001 suggests that presenters forward the public presentation materials prior to the meeting to Ms. Springer via email. The Assistant Secretary for Administration, with the concurrence of the delegate of the General Counsel, formally determined on August 19, 2022, pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App. § 10(d)), that the portion of the meeting dealing with pre-decisional changes to the Commerce Control List and the U.S. export control policies shall be exempt from the provisions relating to public meetings found in 5 U.S.C. App. §§ 10(a)(1) and 10(a)(3). The remaining portions of the meeting will be open to the public. For more information, contact Yvette Springer via email. Yvette Springer, Committee Liaison Officer. [FR Doc. 2022–18445 Filed 8–25–22; 8:45 am] BILLING CODE 3510–JT–P DEPARTMENT OF COMMERCE International Trade Administration [A–560–826] Monosodium Glutamate From the Republic of Indonesia: Final Results of Changed Circumstances Review Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: On July 6, 2022, the U.S. Department of Commerce (Commerce) published its notice of initiation and preliminary results of a changed circumstances review (CCR) of the antidumping duty (AD) order on monosodium glutamate (MSG) from the Republic of Indonesia (Indonesia). For these final results, Commerce finds that PT. Daesang Ingredients Indonesia (PT. Daesang) is the successor-in-interest to PT. Miwon Indonesia (PT. Miwon) and should be assigned the same AD cash deposit rate for purposes of determining AD liability. DATES: Applicable August 26, 2022. FOR FURTHER INFORMATION CONTACT: Andrew Huston, AD/CVD Operations, Office VII, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482–4261. SUPPLEMENTARY INFORMATION: AGENCY: Background On March 10, 2022, PT. Daesang requested that Commerce conduct an expedited CCR to find that PT. Daesang PO 00000 Frm 00007 Fmt 4703 Sfmt 4703 is the successor-in-interest to PT. Miwon.1 On July 6, 2022, Commerce initiated a CCR and preliminarily determined that PT. Daesang is the successor-in-interest to PT. Miwon.2 In the Initiation and Preliminary Results, we provided all interested parties with an opportunity to comment.3 We received no comments from any interested party. Scope of the Order 4 The merchandise covered by the Order is MSG, whether or not blended or in solution with other products. Specifically, MSG that has been blended or is in solution with other product(s) is included in the Order when the resulting mix contains 15 percent or more of MSG by dry weight. Products with which MSG may be blended include, but are not limited to, salts, sugars, starches, maltodextrins, and various seasonings. Further, MSG is included in the Order regardless of physical form (including, but not limited to, in monohydrate or anhydrous form, or as substrates, solutions, dry powders of any particle size, or unfinished forms such as MSG slurry), end-use application, or packaging. MSG in monohydrate form has a molecular formula of C5H8NO4Na-H2O, a Chemical Abstract Service (CAS) registry number of 6106–04–3, and a Unique Ingredient Identifier (UNII) number of W81N5U6R6U. MSG in anhydrous form has a molecular formula of C5H8NO4 Na, a CAS registry number of l42–47–2, and a UNII number of C3C196L9FG. Merchandise covered by the Order is currently classified in the Harmonized Tariff Schedule of the United States (HTSUS) at subheading 2922.42.10.00. Merchandise covered by the Order may also enter under HTSUS subheadings 2922.42.50.00, 2103.90.72.00, 2103.90.74.00, 2103.90.78.00, 2103.90.80.00, and 2103.90.90.91. These tariff classifications, CAS registry numbers, and UNII numbers are 1 See PT. Daesang’s Letter, ‘‘Monosodium Glutamate (MSG) from Indonesia: Request to Initiate a Successor-in-Interest Changed Circumstances Review for PT. Daesang Ingredients Indonesia,’’ dated March 10, 2022. 2 See Monosodium Glutamate from the Republic of Indonesia: Notice of Initiation and Preliminary Results of Changed Circumstances Review, 87 FR 40182 (July 6, 2022) (Initiation and Preliminary Results), and accompanying Preliminary Decision Memorandum. 3 Id., 87 FR at 40183. 4 See Monosodium Glutamate from the People’s Republic of China, and the Republic of Indonesia: Antidumping Duty Orders; and Monosodium Glutamate from the Republic of China: Amended Final Determination of Sales at Less Than Fair Value, 79 FR 70505 (November 26, 2014) (Order). E:\FR\FM\26AUN1.SGM 26AUN1

Agencies

[Federal Register Volume 87, Number 165 (Friday, August 26, 2022)]
[Notices]
[Pages 52505-52506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18470]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-37-2022]


Foreign-Trade Zone (FTZ) 35--Philadelphia, Pennsylvania, 
Notification of Proposed Production Activity, Piramal Pharma Solutions 
(Pharmaceutical Products), Sellersville, Pennsylvania

    Piramal Pharma Solutions submitted a notification of proposed 
production activity to the FTZ Board (the Board) for its facility in 
Sellersville, Pennsylvania under FTZ 35. The notification conforming to 
the requirements of the Board's regulations (15 CFR 400.22) was 
received on August 19, 2022.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz.
    The proposed finished products are bempedoic acid and ezetimibe 
tablets (180/10 milligrams) (duty-free).
    The proposed foreign-status materials are bempedoic acid and 
ezetimibe (duty rate ranges from 4% to 6.5%). The request indicates 
that the materials are subject to duties under Section 301 of the Trade 
Act of 1974 (section 301), depending on the country of origin. The 
applicable Section 301 decisions require subject merchandise to be 
admitted to FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive

[[Page 52506]]

Secretary and sent to: [email protected]. The closing period for their 
receipt is October 5, 2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Christopher Wedderburn at 
[email protected].

    Dated: August 23, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-18470 Filed 8-25-22; 8:45 am]
BILLING CODE 3510-DS-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.